CREDO, the Global Catholic Education Project, and the Lumen Christi Institute are launching a new working paper series on Values, Economics, and Catholic Social Thought. While the series is expected to have a broad focus on economic analysis and reasoning, researchers and practitioners from other social sciences as well as philosophy and theology are encouraged…
Dear CREDO members and readers, we have released our first bulletin! This comes in the form of an email, summarizing all things CREDO (news, events, announcements, job opportunities, and a long etc). It is also available here. The bulletin will replace the Newsletter. We plan to publish the bulletin every first and third Friday of…
CREDO has a monthly virtual seminar! It takes place every first Friday of the month at 10 am EST and explores issues at the intersection of economics and Catholic Social Thought. You can find the program and more information here. If you are interested and want to attend, please send an e-mail to the organizer,…
Dear reader, I am greatly honored, upon the invitation by the President of Catholic Research Economists Development Organization (CREDO), Prof. Joseph Kaboski, to contribute my ideas and realities to CREDO. This is my second year as Bishop in a diocese located in Eastern Uganda, a third world and agrarian economy! I shall try to give…
After a successful first series of workshops, CREDO, in partnership with the Lumen Christi Institute, will run a second series of monthly invite-only CREDO Economics and Catholic Social Thought Virtual Workshop. The interdisciplinary workshop will take place online the first Friday of each month and feature papers addressing the intersecting domains of Economics and Catholic…
CREDO is greatly saddened by the passing of our founding board member Thomas Levergood. Information about religious services can be found here. Below is a reflection from our current President. Thomas Levergood, founder of the Lumen Christi Institute passed away on Friday, August 6, 2021 after a three-month battle with advanced stage cancer. I met…